U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H15ClN2O4S
Molecular Weight 354.809
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of XIPAMIDE

SMILES

CC1=CC=CC(C)=C1NC(=O)C2=C(O)C=C(Cl)C(=C2)S(N)(=O)=O

InChI

InChIKey=MTZBBNMLMNBNJL-UHFFFAOYSA-N
InChI=1S/C15H15ClN2O4S/c1-8-4-3-5-9(2)14(8)18-15(20)10-6-13(23(17,21)22)11(16)7-12(10)19/h3-7,19H,1-2H3,(H,18,20)(H2,17,21,22)

HIDE SMILES / InChI

Molecular Formula C15H15ClN2O4S
Molecular Weight 354.809
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Xipamide is a diuretic of thiazide class. It is used for the treatment of hypertension and edema. The diuretic effect of the drug is due to reduction of sodium reabsorption and increase in potassium excretion.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DIUREXAN

Approved Use

For the treatment of hypertension, either alone or as an adjunct to treatment with anti-hypertensive drugs.
Primary
DIUREXAN

Approved Use

To treat edemas.
PubMed

PubMed

TitleDatePubMed
[Proven in the practice. Follow up of the use confirms high trial value].
2003 Dec 18
[What did the ALLHAT study bring? To do the one without foregoing the other].
2003 Dec 18
Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
2004
Experimental design optimization of a capillary zone electrophoresis method for the screening of several diuretics and ACE inhibitors.
2004 Feb
Effects of pH and the presence of micelles on the resolution of diuretics by reversed-phase liquid chromatography.
2004 Jan 2
[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
2005
Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.
2005 Aug
Combined effect of solvent content, temperature and pH on the chromatographic behaviour of ionisable compounds.
2007 Sep 7
Patents

Patents

Sample Use Guides

Oedema, initially 40 mg daily by mouth, subsequently reduced to 20 mg daily according to response. Hypertension, 20 mg daily as a single morning dose, either alone or  with other antihypertensives.
Route of Administration: Oral
In Vitro Use Guide
The in vitro effects of xipamide in a concentration range of 10(-8) to 10(-2) M were investigated on various Na+ and K+ transport systems in human red blood cells. Xipamide inhibited the anion carrier or DIDS-sensitive LiCO3- -influx starting from a concentration of 10(-5) M.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:24:37 UTC 2023
Edited
by admin
on Fri Dec 15 15:24:37 UTC 2023
Record UNII
4S9EY0NUEC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
XIPAMIDE
INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
MJF-10938
Code English
BENZAMIDE, 5-(AMINOSULFONYL)-4-CHLORO-N-(2,6-DIMETHYLPHENYL)-2-HYDROXY-
Systematic Name English
XIPAMIDE [MART.]
Common Name English
BE-1293
Code English
xipamide [INN]
Common Name English
Xipamide [WHO-DD]
Common Name English
XIPAMIDE [USAN]
Common Name English
MJF 10,938
Code English
4-CHLORO-5-SULFAMOYL-2',6'-SALICYLOXYLIDIDE
Systematic Name English
XIPAMIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C448
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
WHO-ATC C03BA10
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
WHO-VATC QC03BA10
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
Code System Code Type Description
PUBCHEM
26618
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
ChEMBL
CHEMBL517199
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
MERCK INDEX
m11546
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY Merck Index
SMS_ID
100000079360
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
WIKIPEDIA
XIPAMIDE
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
RXCUI
11371
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY RxNorm
EVMPD
SUB00116MIG
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
ECHA (EC/EINECS)
238-216-4
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
FDA UNII
4S9EY0NUEC
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
DRUG BANK
DB13803
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
NCI_THESAURUS
C87708
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
EPA CompTox
DTXSID5023744
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
INN
2689
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
MESH
D014988
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
IUPHAR
7900
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
DRUG CENTRAL
2853
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
CAS
14293-44-8
Created by admin on Fri Dec 15 15:24:37 UTC 2023 , Edited by admin on Fri Dec 15 15:24:37 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY